-
Pharmaceutical packaging is going through a structural reset. What used to be treated as a protective layer is now becoming a strategic lever for sustainability, compliance and patient trust.
EY’s latest India insight frames this shift as urgent, driven by three forces converging at once: tighter global regulations, rising scrutiny of supply-chain emissions, and stronger patient demand for greener choices.
The article specifically calls out the EU’s Packaging and Packaging Waste Regulation (PPWR) and the Carbon Border Adjustment Mechanism (CBAM) as major accelerators that are pushing the industry to reduce packaging waste and cut embedded carbon.The legacy problem is structural. Pharma packaging has long relied on plastics, aluminum foils and complex multi-material laminates. These formats offer strong barrier protection, but are difficult to recycle and expensive to manage at scale.
As regulations tighten, the industry is being forced to move away from “material-heavy, compliance-first” packaging to systems that achieve barrier + recyclability + lower carbon together.
EY describes three concrete transformation lanes emerging across the value chain:
-
Material innovation. The industry is fast-tracking low-carbon and more recyclable alternatives such as mono-material films, green aluminum, and compostable or paper-based solutions. The shift is not just about substituting a single material, but redesigning the full structure so packaging can fit into sustainable waste and recycling ecosystems without compromising safety.
-
Digital packaging. The article highlights how smart labeling and digital traceability are evolving from optional add-ons to core safety and efficiency tools. Digital labels can reduce leaflet waste, improve patient information delivery, and enable real-time monitoring across the supply chain. This is a notable pivot: packaging is now also expected to act as a data carrier that protects brand equity and increases transparency.
-
Circular economy design. Collection, reuse and recycling models are gaining traction. The goal is to move toward closed-loop packaging ecosystems, where sustainability performance is measured beyond the factory gate and across the full lifecycle of the pack.
Within this context, the article spotlights ACG’s sustainable packaging journey as an example of how a packaging leader can align innovation with measurable accountability. ACG is presented as advancing multiple levers in parallel: development of recyclable structures and bio-based alternatives, adoption of renewable energy, and alignment with Science Based Targets initiative (SBTi) commitments.
The case illustrates a broader lesson for the ecosystem: when sustainability is embedded into strategy rather than treated as compliance overhead, packaging becomes a competitive advantage alongside regulatory readiness.
The central takeaway is clear: sustainable pharma packaging is no longer a future aspiration. It is an operational and strategic necessity that will shape which manufacturers and suppliers remain globally competitive.
Companies that combine material redesign, digital traceability and circular models will likely set the benchmark for the next decade in safety, compliance and patient confidence. -
